DirectorsTalk Interviews brings investors closer to the people behind listed companies, markets and sectors. We feature interviews with CEOs from UK, US and Canadian companies, alongside fund managers, analysts and sector specialists, giving audiences direct insight into strategy, performance, opportunities and risks. Each interview is designed to help investors understand the businesses shaping the market and make more informed decisions.
Pennant International Group plc (LON:PEN) CEO Phil Walker joins DirectorsTalk Interviews to discuss a trading update ahead of publication of the Company’s full-year results for the year ended 31 December..
Hardide Plc (LON:HDD) CEO Phil Kirkham joins DirectorsTalk Interviews to discuss annual results for the year ended 30th September 2022. Phil talks us through the financial highlights, explains how he..
Zinc Media Group (LON:ZIN) CEO Mark Browning joins DirectorsTalk Interviews to discuss its trading update to the FY22. Mark talks us through the trading highlights, the market expectations for revenue..
REACT Group Plc (LON:REAT) Chairman Mark Braund joins DirectorsTalk Interviews to discuss final results for the year ended 30 September 2022. Mark talks us through the financial highlights, explains how..
Ferro-Alloy Resources (LON:FAR) CEO Nick Bridgen joins DirectorsTalk Interviews to discuss a general trading update, an update on the planned expansion of the existing processing plant and the receipt of..
Echo Energy plc (LON:ECHO) CEO Martin Hull joins DirectorsTalk Interviews to discuss a commercial update regarding the Company’s gas sales from the producing Santa Cruz Sur assets, onshore Argentina. Martin..
Miton UK Microcap Trust plc (LON:MINI) Co Fund Manager Gervais Williams joins DirectorsTalk to discuss stock picking in a looming recession. Gervais explains his investment strategy with MINI and how..
Valeura Energy Inc. (TSX:VLE) is the topic of conversation when Stephane Foucaud Head of research at Auctus Advisors joins DirectorsTalk Interviews. Stephane shares his thoughts on what looks to be..
Biome Technologies (LON:BIOM) CEO Paul Mines joins DirectorsTalk Interviews to discuss unaudited results for the financial year ended 31 December 2022. With Group revenues for the year in line the..
Christopher Tennant, co-portfolio manager of Fidelity Emerging Markets Limited (LON:FEML), shares his thoughts on the challenges emerging markets have faced over the last twelve months, but also the many opportunities..
Vector Capital (LON:VCAP) CEO Agam Jain joins DirectorsTalk Interviews to discuss an update on trading for the year ended 31 December 2022. Agam reminds us of what the business does..
Team Plc (LON:TEAM) Head of multi asset investments Craig Farley joins DirectorsTalk Interviews to discuss investing through 2023. Craig shares his thoughts on market catalysts and risks that are key..
Volta Finance (LON:VTA, LON:VTAS) is the topic of conversation when Mark Thomas, Analyst at Hardman & Co joins DirectorsTalk Interviews. Mark talks us through his latest report entitled ‘R&A shining..
XP Factory plc (LON:XPF) CEO Richard Harpham joins DirectorsTalk Interviews to discuss results for the year to the 31st December 2022. Richard reminds us of what the two main divisions..
Advanced Oncotherapy (LON:AVO) is the topic of conversation when Dr Martin Hall, Analyst at Hardman & Co joins DirectorsTalk. Martin updates us on some of the recent developments at the..
Accrol Group Holdings (LON:ACRL) CEO Gareth Jenkins talks through the 2023 Investor Presentation with results for the six months ended 31 October 2022. Accrol Group Holdings is the UK’s leading..
Cooks Coffee Company (AQUIS:COOK NZE:CCC) Executive Chairman Keith Jackson joins DirectorsTalk Interviews to discuss a trading update in which it reported a strong sales performance for the year ended 31st..
Apax Global Alpha (LON:APAX) is the topic of conversation when Mark Thomas Analyst at Hardman & Co joins DirectorsTalk Interviews. Mark talks us through his recent report entitled ‘Making Pearls..
Ilika plc (LON:IKA) is the topic of conversation when Clean-tech Equities Specialist at Baden Hill, Dr Tom McColm joins DirectorsTalk Interviews. Tom discusses the half-year report for the six months..
Shield Therapeutics (LON:STX) is the topic of conversation when Dr Martin Hall joins DirectorsTalk Interviews. Martin summarises a number of announcements made by the company recently, explains Accrufer has performed..
